Testing a new way to give the mRNA Covid-19 vaccine
Part of Immune system & allergy, Infections clinical trials.
This study compares how well the mRNA Covid-19 vaccine works when given through different methods (like a needle or a jet injector). It may help find a more comfortable or effective way to get vaccinated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are in generally good health, with or without stable long-term conditions.
- You have not had a Covid-19 vaccine or confirmed Covid-19 in the past year.
- You do not have serious health problems like diabetes, lung disease, heart conditions, or a weakened immune system.
- If you are able to become pregnant, you agree to use effective birth control starting at least 30 days before the study and for its duration.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
This study tests a new nasal spray COVID-19 vaccine to see how it compares to an mRNA booster shot. It is for healthy adults who have already had at least 3 doses of an mRNA COVID-19 vaccine (or 2 doses plus a confirmed COVID infection) and are looking for a needle-free booster option.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
This trial tests a new COVID-19 vaccine called VYD2311, alone or with another COVID-19 vaccine, in healthy adults. The goal is to see if it is safe and helps your body fight the virus.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
Hear when a new SARS CoV-2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.